Enrichment of IGF-1R and PPARγ signalling pathways in orbital inflammatory diseases: steps toward understanding pathogenesis
Authors:
Open Access
- 26 February 2021
- journal article
- research article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 106 (7) , 1012-1017
Abstract
Background Orbital inflammatory disease (OID) encompasses a wide range of pathology including thyroid-associated orbitopathy (TAO), granulomatosis with polyangiitis (GPA), sarcoidosis and non-specific orbital inflammation (NSOI), accounting for up to 6% of orbital diseases. Understanding the underlying pathophysiology of OID can improve diagnosis and help target therapy. Aims To test the hypothesis that shared signalling pathways are activated in different forms of OID. Methods In this secondary analysis, pathway analysis was performed on the previously reported differentially expressed genes from orbital adipose tissue using patients with OID and healthy controls who were characterised by microarray. For the original publications, tissue specimens were collected from oculoplastic surgeons at 10 international centres representing four countries (USA, Canada, Australia and Saudi Arabia). Diagnoses were independently confirmed by two masked ocular pathologists (DJW, HEG). Gene expression profiling analysis was performed at the Oregon Health & Science University. Eighty-three participants were included: 25 with TAO, 6 with orbital GPA, 7 with orbital sarcoidosis, 25 with NSOI and 20 healthy controls. Results Among the 83 subjects (mean (SD) age, 52.8 (18.3) years; 70% (n=58) female), those with OID demonstrated perturbation of the downstream gene expressions of the IGF-1R (MAPK/RAS/RAF/MEK/ERK and PI3K/Akt/mTOR pathways), peroxisome proliferator-activated receptor-γ (PPARγ), adipocytokine and AMPK signalling pathways compared with healthy controls. Specifically, GPA samples differed from controls in gene expression within the insulin-like growth factor-1 receptor (IGF-1R, PI3K-Akt (p=0.001), RAS (p=0.005)), PPARγ (p=0.002), adipocytokine (p=0.004) or AMPK (p=Conclusions Although OID includes a heterogenous group of pathologies, TAO, GPA, sarcoidosis and NSOI share enrichment of common gene signalling pathways, namely IGF-1R, PPARγ, adipocytokine and AMPK. Pathway analyses of gene expression suggest that other forms of orbital inflammation in addition to TAO may benefit from blockade of IGF-1R signalling pathways.Keywords
Funding Information
- Grandmaison Fund for Autoimmunity Research (no award number from this source)
- Stan and Madelle Rosenfeld Family Trust (no award number from this source)
- Clinical Center (EY020249, NEI Core Grant P30 EY010572)
- William H. and Mary L. Bauman Foundation (no award number from this source)
- Research to Prevent Blindness (no award number from this source)
This publication has 46 references indexed in Scilit:
- Teprotumumab for the Treatment of Active Thyroid Eye DiseaseNew England Journal of Medicine, 2020
- Teprotumumab for Thyroid-Associated OphthalmopathyNew England Journal of Medicine, 2017
- Building the Case for Insulin-Like Growth Factor Receptor-I Involvement in Thyroid-Associated OphthalmopathyFrontiers in Endocrinology, 2017
- Pathogenesis of thyroid eye disease: review and update on molecular mechanismsBritish Journal of Ophthalmology, 2015
- Orbital pseudotumor can be a localized form of granulomatosis with polyangiitis as revealed by gene expression profilingExperimental and Molecular Pathology, 2015
- Bidirectional TSH and IGF-1 Receptor Cross Talk Mediates Stimulation of Hyaluronan Secretion by Graves' Disease ImmunoglobinsThe Journal of Clinical Endocrinology & Metabolism, 2015
- Current Concepts in the Molecular Pathogenesis of Thyroid-Associated OphthalmopathyInvestigative Ophthalmology & Visual Science, 2014
- Increased Expression of TSH Receptor by Fibrocytes in Thyroid-Associated Ophthalmopathy Leads to Chemokine ProductionThe Journal of Clinical Endocrinology & Metabolism, 2012
- Evidence for an Association between Thyroid-Stimulating Hormone and Insulin-Like Growth Factor 1 Receptors: A Tale of Two Antigens Implicated in Graves’ DiseaseThe Journal of Immunology, 2008
- Characterization of Thyrotropin Receptor Antibody-Induced Signaling CascadesEndocrinology, 2008